[1]
J. Berendika, “First experiences with the use of targeted and immunotherapy in the treatment of cutaneous melanoma: a single Centre experience”, Scr Med, vol. 53, no. 1, pp. 29–35, Mar. 2022, doi: 10.5937/scriptamed53-35184.